RRM2 and Its Role in Liver Cancer Progression
Author Information
Author(s): Wu Dandan, Sun Xinning, Li Xin, Zuo Zongchao, Yan Dong, Yin Wu
Primary Institution: State Key Lab of Pharmaceutical Biotechnology, College of Life Sciences in Nanjing University
Hypothesis
RRM2 regulates hepatocellular carcinoma progression through activation of TGF-β/Smad signaling and hepatitis B virus transcription.
Conclusion
RRM2 is involved in the progression of HCC by activating the TGF-β/Smad signaling pathway and increasing HBV transcription in HBV-expressing HCC cells.
Supporting Evidence
- RRM2 expression is significantly elevated in HCC, correlating with poor clinical outcomes.
- RRM2 knockdown decreased HBV RNA, pgRNA, cccDNA, and HBV DNA levels in infected cells.
- RRM2 promotes HCC cell growth and metastasis through TGF-β/Smad signaling activation.
Takeaway
RRM2 is a protein that helps liver cancer grow and spread, and blocking it might help treat the disease.
Methodology
Bioinformatics analyses and various pharmacological methods including MTT, colony formation, EdU, Western blotting, Q-PCR, wound healing, Transwell assays, and immunohistochemistry were used to study RRM2's effects in HCC.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website